Showing results (121-130 of 153) with videos related to
Sort By:
Pageof 16
Journal of Medical Virology|February 1, 1993
Delayed type hypersensitivity to human cytomegalovirusR Gupta, E Gonczol, M L Manning, et al.JAMA|April 16, 1982
Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantationF T Serota, S E Starr, C K Bryan, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1987
Gastroenteritis caused by human rotaviruses (serotype three) in a suckling mouse modelL M Bell, H F Clark, E A O'Brien, et al.The Journal of Infectious Diseases|December 16, 1998
Cost of varicella in France: a study in day care centersP Saddier, D Floret, H A Guess, et al.American Journal of Diseases of Children (1960)|November 1, 1985
Imipenem/cilastatin for the treatment of infections in hospitalized childrenG Alpert, R Dagan, E Connor, et al.American Journal of Diseases of Children (1960)|March 1, 1988
Rotavirus serotype-specific neutralizing activity in human milkL M Bell, H F Clark, P A Offit, et al.Vaccine|April 1, 1996
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell responseK Berencsi, E Gönczöl, V Endresz, et al.Journal of Clinical Microbiology|August 1, 1984
Rotavirus-specific antibodies in fetal bovine serum and commercial preparations of serum albuminP A Offit, H F Clark, A H Taylor, et al.Virology|June 12, 1999
Involvement of a p53-dependent pathway in rubella virus-induced apoptosisK Megyeri, K Berencsi, T D Halazonetis, et al.The Journal of Infectious Diseases|November 1, 1990
An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodiesG S Marshall, R P Ricciardi, R F Rando, et al.Pageof 16